The World Health Organization
today announced that clinical
trials of a preventative vaccine
for the Ebola virus made by
British pharma company
GlaxoSmithKline may begin next month and made
available by 2015.
According to AFP, Jean-Marie
Okwo Bele, the WHO’s head of
vaccines and immunisation,
said this; adding that he was
optimistic about making the
vaccine commercially available.
“We are targeting September for the start of clinical trials, first in the United States and certainly in African countries, since that’s where we have the cases. We think that if we start in September, we could already have results by the end of the year. And since this is an emergency, we can put emergency procedures in place … so that we can have a vaccine available by 2015.”
There is currently no available
cure or vaccine for Ebola, a
virus that causes severe fever
and, in the worst cases,
unstoppable bleeding. It has
claimed close to 1,000 lives in the latest epidemic to spread
across west Africa this year.
Several vaccines are being
tested, and a treatment made
by San Diego-based Mapp
Biopharmaceutical, ZMapp, has shown promising results on
monkeys and may have been
effective in treating two
Americans recently infected in Africa

So, are they saying the infected should either die or wait till next year?

Tazmode: So, are they saying the infected should either die or wait till next year?

It is a vaccine....meant to protect the uninfected from coming down with the virus.